CLINICAL_TRIALS
trial_result
· 2018-10-26
Clinical Trial Update: Safety and Immunogenicity of Various Formulations of Live Attenuated Tetravalent Dengue Vaccine in Healthy US Adults [Phase 2]
Summary
Phase 2 clinical trial update evaluating safety and immunogenicity of various formulations of a live attenuated tetravalent dengue vaccine in healthy adults; re…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: U.S. Army Medical Research and Development Command | Conditions: Dengue | Phase 2 | Status: COMPLETED | Results posted: 2018-10-26